| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |